Transcatheter Aortic Valve Replacement: Comparing Transfemoral, Transcarotid and Transcaval Access.

CONCLUSIONS: Patients unsuitable for TF TAVR treated with TC or TCav access had 30-day/in-hospital and 1-year survival similar to a contemporary cohort undergoing TF access. Avoiding surgical entry to the chest may offer procedural and intermediate term outcomes equivalent to TF TAVR.
PMID: 29758214 [PubMed - as supplied by publisher]

Source: The Annals of Thoracic Surgery - May 11, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Paone G, Eng M, Kabbani LS, Borgi J, Peterson E, Novitsky B, Burroughs B, Wang DD, O'Neill WW, Greenbaum AS Tags: Ann Thorac Surg Source Type: research